Treatment Innovations

CereVasc Scales Up: New Massachusetts Facility Signals Commercial Readiness for eShunt System

• Treatment Innovations

CereVasc Scales Up: New Massachusetts Facility Signals Commercial Readiness for eShunt System

Nila Kartika Wati August 4, 2026

In a significant stride toward transforming the landscape of neurosurgical care, CereVasc, a medical device company at...

Read More Read more about CereVasc Scales Up: New Massachusetts Facility Signals Commercial Readiness for eShunt System

The Evolution of Integrated Care: Analyzing Health and Social Care Under Andy Burnham

• Treatment Innovations

The Evolution of Integrated Care: Analyzing Health and Social Care Under Andy Burnham

Nana Wu August 4, 2026

The integration of health and social care has long been the "holy grail" of public policy in...

Read More Read more about The Evolution of Integrated Care: Analyzing Health and Social Care Under Andy Burnham

Consolidation in Neuroscience: The Strategic Merger of Indivior and Supernus

• Treatment Innovations

Consolidation in Neuroscience: The Strategic Merger of Indivior and Supernus

Evan Lee Salim August 4, 2026

By Jonathan Gardner | Published August 3, 2026 In a landmark deal set to reshape the landscape...

Read More Read more about Consolidation in Neuroscience: The Strategic Merger of Indivior and Supernus

RadNet’s DeepHealth Secures FDA Clearance for AI-Powered Breast Ultrasound System: A New Era in Diagnostic Precision

• Treatment Innovations

RadNet’s DeepHealth Secures FDA Clearance for AI-Powered Breast Ultrasound System: A New Era in Diagnostic Precision

Raul Delapena Setiawan August 3, 2026

In a significant leap forward for oncological imaging, DeepHealth—a subsidiary of the national diagnostic imaging leader RadNet—has...

Read More Read more about RadNet’s DeepHealth Secures FDA Clearance for AI-Powered Breast Ultrasound System: A New Era in Diagnostic Precision

The $400 Billion Question: Wall Street Rejects Potential AstraZeneca-Bristol Myers Squibb Megamerger

• Treatment Innovations

The $400 Billion Question: Wall Street Rejects Potential AstraZeneca-Bristol Myers Squibb Megamerger

Iffa Jayyana August 3, 2026

In a development that has sent shockwaves through the global pharmaceutical landscape, rumors of a potential megamerger...

Read More Read more about The $400 Billion Question: Wall Street Rejects Potential AstraZeneca-Bristol Myers Squibb Megamerger

Strategic Expansion: Profusa Targets G3 Vision Labs in Ambitious Bid to Dominate Diagnostics Landscape

• Treatment Innovations

Strategic Expansion: Profusa Targets G3 Vision Labs in Ambitious Bid to Dominate Diagnostics Landscape

Siti Muinah August 3, 2026

In a move that signals a significant pivot toward integrated healthcare solutions, California-based digital health innovator Profusa...

Read More Read more about Strategic Expansion: Profusa Targets G3 Vision Labs in Ambitious Bid to Dominate Diagnostics Landscape

The Battle for the 340B Program: A Multi-Billion Dollar Tug-of-War

• Treatment Innovations

The Battle for the 340B Program: A Multi-Billion Dollar Tug-of-War

Asro August 3, 2026

The federal 340B Drug Pricing Program, once a niche mechanism designed to help safety-net providers stretch thin...

Read More Read more about The Battle for the 340B Program: A Multi-Billion Dollar Tug-of-War

Accelerating Early Detection: Median Technologies Partners with Olea Medical to Scale eyonis™ LCS

• Treatment Innovations

Accelerating Early Detection: Median Technologies Partners with Olea Medical to Scale eyonis™ LCS

Ammar Sabilarrohman August 2, 2026

In a move set to redefine the landscape of pulmonary oncology, Median Technologies has announced a strategic...

Read More Read more about Accelerating Early Detection: Median Technologies Partners with Olea Medical to Scale eyonis™ LCS

The Evolution of Esketamine: J&J Pushes Remission as the New Benchmark for Treatment-Resistant Depression

• Treatment Innovations

The Evolution of Esketamine: J&J Pushes Remission as the New Benchmark for Treatment-Resistant Depression

Nana Wu August 2, 2026

More than six decades after chemist Calvin Stevens first synthesized ketamine at Parke-Davis—an endeavor initially aimed at...

Read More Read more about The Evolution of Esketamine: J&J Pushes Remission as the New Benchmark for Treatment-Resistant Depression

Total Flow Medical Secures FDA Clearance for Innovative TFA Cannula: A New Era in Limb Perfusion During Cardiac Surgery

• Treatment Innovations

Total Flow Medical Secures FDA Clearance for Innovative TFA Cannula: A New Era in Limb Perfusion During Cardiac Surgery

Asro August 2, 2026

In a significant development for the field of cardiovascular surgery, Total Flow Medical has announced that it...

Read More Read more about Total Flow Medical Secures FDA Clearance for Innovative TFA Cannula: A New Era in Limb Perfusion During Cardiac Surgery